Please assess the completion status of the following clinical trial:

Trial Title: Acute Effect of Mometasone on Beta-adrenergic Airway and Airway Vascular Relaxation in Severe Asthma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 9.0

Eligibility Criteria:
Inclusion Criteria:Fifteen non-smokers (males and females between the ages of 18 and 65 years) with physician-diagnosed moderate persistent asthma and FEV1 \< 75% of predicted.~Exclusion Criteria:Cardiovascular disease and use of cardiovascular medications, pregnancy, use of oral controller medication for asthma (methylxanthines, systemic glucocorticosteroids, leukotriene modifiers), an acute respiratory infection within 4 weeks before enrollment~-

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- mometasone 400 mcg - 30 min (Type: EXPERIMENTAL): randomly assigned intervention
- mometasone 400 mcg simultaneous (Type: EXPERIMENTAL): randomly assigned intervention
- placebo- 30 min (Type: PLACEBO_COMPARATOR): randomly assigned intervention
- placebo simultaneous (Type: PLACEBO_COMPARATOR): randomly assigned intervention
- mometasone 400 mcg - 60 min (Type: EXPERIMENTAL): randomly assigned intervention
- placebo- 60 min (Type: PLACEBO_COMPARATOR): randomly assigned intervention
- mometasone 200 mcg - 30 min (Type: EXPERIMENTAL): randomly assigned intervention
- mometasone 200 mcg - 60 min (Type: EXPERIMENTAL): randomly assigned intervention
- mometasone 200 mcg simultaneous (Type: EXPERIMENTAL): randomly assigned intervention

Based on this trial design, predict the completion outcome and termination type (if applicable).